Crossmark

Effective management of concomitant rheumatoid arthritis and T-large granular lymphocyte leukemia using reduced-dose upadacitinib

Crossref DOI link: https://doi.org/10.1007/s10787-025-01773-3

Published Online: 2025-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nigro, Angelo https://orcid.org/0009-0001-0802-6825
License Information

Text and Data Mining valid from 2025-05-16

Version of Record valid from 2025-05-16
More Information

Article History

Received: 14 April 2025

Accepted: 24 April 2025

First Online: 16 May 2025

Declarations

:

:

: The author declares no competing interests.